Boston Scientific
Trade Boston Scientific 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
BSX Key Statistics
Stock Snapshot
With a market cap of 133.42B, Boston Scientific(BSX) trades at $90.10. The stock has a price-to-earnings ratio of 50.14.
On 2026-01-16, Boston Scientific(BSX) shares started trading at $88.26, with intraday highs of — and lows of —.
Trading volume for Boston Scientific(BSX) stock has reached 1.62K, versus its average volume of 10.29M.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.
BSX News
Claim 70% Off TipRanks Premium Boston Scientific ( (BSX) ) has issued an update. On January 14, 2026, Boston Scientific entered into a definitive agreement to...
BTIG analyst Ryan Zimmerman downgraded Penumbra (PEN) to Neutral from Buy and removed the firm’s prior $349 price target after the announcement that Boston Scie...
In early trading on Thursday, shares of Amcor topped the list of the day's best performing components of the S&P 500 index, trading up 399.1%. Year to date, Amc...
Analyst ratings
95%
of 37 ratingsMore BSX News
Shares in medical devices business Penumbra (PEN) rocketed 13% in pre-market trading today after it was bought by peer Boston Scientific (BSX) for $14.5 billion...
Boston Scientific Corporation (NYSE:BSX) stock fell Thursday, while Penumbra, Inc. (NYSE:PEN) climbed, following news that the medical device giant agreed to ac...
Boston Scientific, Inc. BSX recently announced that it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held fi...
Penumbra, which developed the Lightning Bolt 6X, to remove blood clots below the knee, is now being acquired by Boston Scientific. Boston Scientific is spendin...
Boston Scientific (BSX) on Thursday announced a definitive agreement to acquire Penumbra (PEN) in a cash and stock transaction that values the Alameda-based hea...
For investors wondering whether Boston Scientific's share price still offers value after its long run, or whether much of the easier upside may already be behin...
Citi removed Boston Scientific (BSX) from the firm’s Focus List while keeping a Buy rating on the shares with a $130 price target The removal follows the compan...